diclofenac has been researched along with Heartburn in 3 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Heartburn: Substernal pain or burning sensation, usually associated with regurgitation of gastric juice into the esophagus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Compared with placebo, diclofenac significantly reduced the APSS for heartburn (82." | 9.20 | The Nonsteroidal Anti-inflammatory Drug Diclofenac Reduces Acid-Induced Heartburn Symptoms in Healthy Volunteers. ( Fukui, H; Kondo, T; Miwa, H; Okada, H; Oshima, T; Tomita, T; Watari, J, 2015) |
| "The efficacy and tolerability of aceclofenac (100 mg bid; n = 109), a new non-steroidal anti-inflammatory agent, was compared to that of indomethacin (50 mg bid; n = 110) in a multi-centre, 12-week, randomized, double-blind clinical trial in patients with rheumatoid arthritis." | 9.08 | The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis. ( Bowdler, J; Kornasoff, D; Maisenbacher, J; Raber, A, 1996) |
| "Compared with placebo, diclofenac significantly reduced the APSS for heartburn (82." | 5.20 | The Nonsteroidal Anti-inflammatory Drug Diclofenac Reduces Acid-Induced Heartburn Symptoms in Healthy Volunteers. ( Fukui, H; Kondo, T; Miwa, H; Okada, H; Oshima, T; Tomita, T; Watari, J, 2015) |
| "The efficacy and tolerability of aceclofenac (100 mg bid; n = 109), a new non-steroidal anti-inflammatory agent, was compared to that of indomethacin (50 mg bid; n = 110) in a multi-centre, 12-week, randomized, double-blind clinical trial in patients with rheumatoid arthritis." | 5.08 | The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis. ( Bowdler, J; Kornasoff, D; Maisenbacher, J; Raber, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ferreira-Silva, J | 1 |
| Morais, R | 1 |
| Macedo, G | 1 |
| Kondo, T | 1 |
| Oshima, T | 1 |
| Tomita, T | 1 |
| Fukui, H | 1 |
| Okada, H | 1 |
| Watari, J | 1 |
| Miwa, H | 1 |
| Kornasoff, D | 1 |
| Maisenbacher, J | 1 |
| Bowdler, J | 1 |
| Raber, A | 1 |
2 trials available for diclofenac and Heartburn
| Article | Year |
|---|---|
The Nonsteroidal Anti-inflammatory Drug Diclofenac Reduces Acid-Induced Heartburn Symptoms in Healthy Volunteers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Diclofenac; Dinoprostone; Double | 2015 |
The efficacy and tolerability of aceclofenac compared to indomethacin in patients with rheumatoid arthritis.
Topics: Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; El | 1996 |
1 other study available for diclofenac and Heartburn
| Article | Year |
|---|---|
An Unusual Cause of Regurgitation and Heartburn In a Patient With Fundoplication.
Topics: Arthritis; Biopsy; Diclofenac; Endoscopy, Digestive System; Esophageal Mucosa; Esophagitis; Female; | 2020 |